Status:
RECRUITING
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Lead Sponsor:
University of Monastir
Conditions:
Head Pain
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Detailed Description
Rate of Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
Eligibility Criteria
Inclusion
- informed consent
- age \>18 years
- Acute non-traumatic acute headaches
- patients treated in ED
- Magnesium sulfate and aspirin administered intravenously (IV)
Exclusion
- Current regular use of analgesics, anticonvulsants or antidepressants
- Renal disorder with a low glomerular filtration rate (\<60 ml/min)
- Neuromuscular disorder
- Pregnant woman
- Contrindication
- Allergy to NSAID
- Traumatic Headache
- Chronic headache ( headache occurring at least 15 days per month for at least 3 months)
- Hemodynamic instability
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT05325580
Start Date
December 1 2021
End Date
December 30 2026
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Monasrtir
Monastir, Tunisia, 5060